Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43132

CCDC93 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The CCDC93 Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population targeting CCDC93 in the HAP1 near-haploid human cell line. CCDC93 is a scaffolding component of the WASH complex that interacts with WASHC1 and VPS35 to regulate endosomal actin polymerization, enabling cargo sorting of ITGB1 and TFRC. This model is ideal for investigating endosomal recycling and actin cytoskeleton dynamics. Related applications include transferrin recycling assays, co-immunoprecipitation, and functional genomics screens. The HAP1 background offers a genetically tractable platform for studying trafficking defects associated with neurodegenerative disorders.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    CCDC93

    Gene Identifier

    NCBI Gene ID 54520

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CCDC93 Knockout HAP1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt target gene expression of CCDC93 in the HAP1 human near-haploid cell line. This loss-of-function model enables researchers to investigate the cellular functions of CCDC93 without reliance on pharmacological inhibition or RNA interference, providing a stable genetic background for functional studies. The polyclonal nature of the knockout pool ensures representation of diverse editing events, offering a practical tool for screening experiments and pathway analysis.

The HAP1 cell line is a male-derived human near-haploid chronic myeloid leukemia line originating from the KBM-7 lineage. Its near-haploid karyotype simplifies genetic manipulation and facilitates knockout generation, as only one allele needs to be disrupted to achieve a functional null phenotype in many loci. HAP1 cells are widely employed as a haploid genetics model and a versatile functional genomics screening platform, enabling high-throughput interrogation of gene function in a human context.

CCDC93 encodes an essential scaffolding component of the WASH (Wiskott-Aldrich Syndrome Protein and SCAR Homolog) complex regulatory module. This protein directly interacts with multiple WASH complex members, including WASHC1, WASHC2, WASHC3, WASHC4, and WASHC5, as well as accessory factors such as KIAA1033 and C16orf62. CCDC93 cooperates with the retromer components VPS35 and VPS29 to spatially organize branched actin assembly on endosomal membranes through activation of the Arp2/3 complex. Downstream, CCDC93-dependent regulation promotes F-actin polymerization and endosomal tubulation, which are critical for the efficient sorting and recycling of internalized transmembrane cargo proteins, notably integrin beta-1 (ITGB1) and transferrin receptor (TFRC). While upstream regulatory signals controlling CCDC93 remain uncharacterized, its central role in the WASH complex positions it as a key node linking endosomal membrane dynamics to the actin cytoskeleton.

Disruption of CCDC93 in the HAP1 background is anticipated to impair WASH complex-mediated actin polymerization on endosomes, leading to defects in retromer-dependent cargo sorting and endosomal tubule formation. This knockout model therefore provides a physiologically relevant system to dissect the mechanistic interplay between the WASH complex and retromer in governing endosomal recycling pathways. The near-haploid nature of HAP1 cells further streamlines genetic complementation studies and enables clean genotype-phenotype correlations in trafficking assays, offering an advantage over diploid cell models where compensatory mechanisms may mask knockout effects.

The CCDC93 Knockout HAP1 Polyclonal Cells are suited for a diverse array of experimental applications, including functional genomics screens, endosomal trafficking studies, and actin cytoskeleton research. Representative assays that can be performed with this model include Western blotting to confirm loss of CCDC93 protein expression, immunofluorescence to visualize endosomal tubulation defects, transferrin recycling assays coupled with flow cytometry to quantify cargo sorting efficiency, and co-immunoprecipitation to assess WASH complex integrity. The knockout cells also enable targeted investigation of ITGB1 and TFRC recycling dynamics. Researchers can leverage this system to explore how endosomal trafficking defects contribute to diseases such as neurodegenerative disorders. For technical inquiries or further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)